A Wellcome report yesterday says more research is needed on drug-resistant bacterial infections (DRIs), but current data indicate that DRIs can be more likely to occur—and have more serious ramifications—in people with health conditions like cancer or who have received extensive treatment such as surgery.
The London School of Hygiene and Tropical Medicine (LSHTM) announced today that it is partnering with Johnson & Johnson (J&J) to launch a center focused on research into antimicrobial resistance and tuberculosis (TB).
The World Health Organization (WHO) today issued an update to its consolidated guidelines on the detection of tuberculosis (TB) and drug-resistant TB.
Following China's 70-year battle against malaria, the World Health Organization (WHO) today announced that the country has been awarded a malaria-free certification. In a statement, the WHO said that the achievement is notable, given that China reported about 30 million cases each year in the 1940s.
The Centers for Disease Control and Prevention (CDC) said this week that it's investigating a cluster of tuberculosis (TB) infections in patients who've recently undergone spinal surgery that used a single lot of a bone repair product.
US lawmakers today re-introduced a bill to reinvigorate the antibiotic development market.
Until COVID, TB was the world's top infectious cause of death, and the pandemic threatens to derail efforts to curtail it.
The results of a National Institutes of Health-funded phase 2 study indicate the new tuberculosis (TB) drugs delamanid and bedaquiline, when combined, have only a modest effect on the electrical activity of the heart, US, South African, and Peruvian researchers reported last week in the Lancet Infectious Diseases.
A 4-year-old boy living outside of Milan with no travel history is now the earliest confirmed SARS-CoV-2 case in Italy, a team based in Italy reported in a research letter to Emerging Infectious Diseases yesterday.
A study published late last week in the British Dental Journal suggests that restricted access to dental care in England during the early months of the COVID-19 pandemic resulted in a sharp rise in dental antibiotic prescribing.